Neuro-Oncology is a distinct evolving subspecialty that merges neurology with oncology. While neuro-oncologists are considered the experts in both the diagnosis and management of primary and metastatic brain tumors and neurologic complications of cancer, they are dependent on the strength of the multispecialty team comprised of neurosurgeons, radiation oncologists, neuropathologists, neuroradiologists and neuropsychologists. In addition, the multidisciplinary team of nurses, social workers, physical therapists and speech therapists contribute to improved outcomes for the patient with neurological complications of cancer.
Advances in neuro-oncology have increased our understanding of the molecular biology of brain tumors. Advances in surgical techniques and intraoperative imaging have improved outcomes. We have seen an integration of newly identified molecular biomarkers into clinical trials in an effort to provide individualized patient treatments. The use of non-invasive methods of detecting tumor proliferation, invasion and angiogenesis within the brain is rapidly growing. Every day brings us closer to the promise that molecular profiling of tumors will predict tumor response to therapy and guide clinical management decisions. The scientific and practice community has also been more receptive to the significant role of supportive care in the management of patients with brain tumors.
As your colleagues, we would like to extend an invitation for you to attend our 2nd annual conference. We hope you will join us for a multidisciplinary discussion on the recent progress and future advances in the treatment of brain tumors.
John F. Alksne, MD
Bob Carter, MD, PhD
Santosh Kesari, MD, PhD
Internists, neurosurgeons, neurologists, oncologists, primary care physicians, pathologists, radiologists, neuropsychologists and allied health professionals.
At the conclusion of this activity, participants should be able to:
For technical comments or questions, contact the webmaster.
Copyright 2011, University of California, San Diego. All rights reserved.